Daiichi Sankyo
Victoria Amari is an experienced communications professional currently serving as Director of Global Oncology Product Communications at Daiichi Sankyo, Inc. since July 2020. With a career spanning over two decades, Amari has held various leadership roles, including Director of Corporate Affairs Communications at Bristol Myers Squibb and Vice President positions at Zeno Group and Ruder Finn. In addition to professional endeavors, Amari has been an active Board Member and National Advisory Council Member at the Peggy Lillis Foundation since April 2010. Amari holds a Bachelor of Science degree in Mass Communication & Public Relations from Boston University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Daiichi Sankyo
21 followers
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Daiichi Sankyo Group and Ranbaxy Group. The Daiichi Sankyo Group segment comprises of Daiichi Sankyo Co., Ltd. and its subsidiaries. The Ranbaxy Group segment includes its core company, Ranbaxy Laboratories Ltd. Both group segments deal with business activities in prescription drugs and general pharmaceutical products. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.